Live feed
Filing
SC 13G
SC 13G0001214659-23-004596·Quince Therapeutics, Inc.
Schedule 13G ownership disclosure
QUINCE THERAPEUTICS INC
Security class unavailable · CUSIP: 22053A107
Event date: 2023-03-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-23-004596
- Form type
- SC 13G
- Filer
- Quince Therapeutics, Inc.
- CIK
- CIK 1662774
- Filed
- Mar 31, 2023
- Reporting period
- Mar 21, 2023
- Description
- Schedule 13G beneficial ownership